
Capital Markets
Emerging Companies & Venture Capital
Mergers & Acquisitions
Public Company Representation
Healthcare & Life Sciences
Technology
Spencer B. Ricks is a Partner at Latham & Watkins in Boston, specializing in advising entrepreneurs, start-ups, and emerging companies in the technology, life sciences, and clean energy sectors. With a focus on corporate law, Spencer guides clients through the entire corporate life cycle, including venture capital financings, mergers and acquisitions, and public offerings. He also represents mature companies in strategic investments and commercial collaborations. Spencer is actively involved in the local community, providing pro bono legal services to asylum petitioners and survivors of domestic violence. He holds a JD from New York University and a BA from Brigham Young University.
Technology
Life Sciences
Clean Energy & Sustainability
Other
- Dechra Pharmaceuticals Limited acquired Invetx, Inc. from Invetx, Inc. in a acquisition on 2024-07-19. - Deal value was 5200000000 (source: Extracted) Sector: Animal Health; Location: USA. - Acquirer-side legal counsel was not specified.
Jul 19 2024
520M
M&A
Partner
2021 – Unknown
Associate
2017 – 2021
Summer Associate
2010 – 2010
Spanish Instructor
- Divert, Inc. acted as the acquirer in this Financing transaction. - The acquisition targeted assets operating in the Infrastructure sector. - The transaction was announced on 22 Sep 2023 with a reported value of 10000000000.0.
Sep 22 2023
1B
Finance
1 min
2006 – 2009
Spanish Instructor
2006 – 2009
Spanish Instructor
2008 – 2009
Representative
2004 – 2006